231 related articles for article (PubMed ID: 32379491)
1. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
Wang C; Wang C; Qiu C; Su Z
Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
[No Abstract] [Full Text] [Related]
2. MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a.
Li X; Liu K; Zhou W; Jiang Z
Cancer Biomark; 2020; 27(1):105-111. PubMed ID: 31771044
[TBL] [Abstract][Full Text] [Related]
3. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.
Huang R; Song X; Wang CM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
[TBL] [Abstract][Full Text] [Related]
6. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
[No Abstract] [Full Text] [Related]
7. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
9. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
[TBL] [Abstract][Full Text] [Related]
11. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3.
Liao WW; Zhang C; Liu FR; Wang WJ
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1277-1285. PubMed ID: 29565484
[TBL] [Abstract][Full Text] [Related]
13. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
Zhu QL; Li Z; Lv CM; Wang W
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
[TBL] [Abstract][Full Text] [Related]
14. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
[TBL] [Abstract][Full Text] [Related]
15. MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells.
Du SL; Xu LY; Gao P; Liu QS; Lu FF; Mo ZH; Fan ZZ; Cheng XL; Dong ZH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8833-8840. PubMed ID: 31696470
[TBL] [Abstract][Full Text] [Related]
16. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
[TBL] [Abstract][Full Text] [Related]
17. Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain.
Pang X; Zhou Z; Yu Z; Han L; Lin Z; Ao X; Liu C; He Y; Ponnusamy M; Li P; Wang J
RNA Biol; 2019 Feb; 16(2):233-248. PubMed ID: 30628514
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p.
Wang X; Zhang Y; Li W; Liu X
J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
